APA

Shen J., Samul R., Silva R. L., Akiyama H., Liu H., Saishin Y., Hackett S. F., Zinnen S., Kossen K., Fosnaugh K., Vargeese C., Gomez A., Bouhana K., Aitchison R., Pavco P. & Campochiaro P. A. (20060629). Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. : Gene therapy.

Chicago

Shen J, Samul R, Silva R L, Akiyama H, Liu H, Saishin Y, Hackett S F, Zinnen S, Kossen K, Fosnaugh K, Vargeese C, Gomez A, Bouhana K, Aitchison R, Pavco P and Campochiaro P A. 20060629. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. : Gene therapy.

Harvard

Shen J., Samul R., Silva R. L., Akiyama H., Liu H., Saishin Y., Hackett S. F., Zinnen S., Kossen K., Fosnaugh K., Vargeese C., Gomez A., Bouhana K., Aitchison R., Pavco P. and Campochiaro P. A. (20060629). Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. : Gene therapy.

MLA

Shen J, Samul R, Silva R L, Akiyama H, Liu H, Saishin Y, Hackett S F, Zinnen S, Kossen K, Fosnaugh K, Vargeese C, Gomez A, Bouhana K, Aitchison R, Pavco P and Campochiaro P A. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. : Gene therapy. 20060629.